Greig NH - Search Results

1

Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental Alzheimer therapeutic, bisnorcymserine.

Kamal MA, Klein P, Yu QS, Tweedie D, Li Y, Holloway HW, Greig NH. Kamal MA, et al. Among authors: greig nh. J Alzheimers Dis. 2006 Sep;10(1):43-51. doi: 10.3233/jad-2006-10108. J Alzheimers Dis. 2006. PMID: 16988481

2

Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.

Freo U, Holloway HW, Greig NH, Soncrant TT. Freo U, et al. Among authors: greig nh. Psychopharmacology (Berl). 1992;107(1):30-8. doi: 10.1007/BF02244962. Psychopharmacology (Berl). 1992. PMID: 1534179

3

Regional brain metabolic responsivity to the muscarinic cholinergic agonist arecoline is similar in young and aged Fischer-344 rats.

Soncrant TT, Holloway HW, Greig NH, Rapoport SI. Soncrant TT, et al. Among authors: greig nh. Brain Res. 1989 May 22;487(2):255-66. doi: 10.1016/0006-8993(89)90830-5. Brain Res. 1989. PMID: 2731046

4

Delivery of human interferon-alpha to brain by transient osmotic blood-brain barrier modification in the rat.

Greig NH, Fredericks WR, Holloway HW, Soncrant TT, Rapoport SI. Greig NH, et al. J Pharmacol Exp Ther. 1988 May;245(2):581-6. J Pharmacol Exp Ther. 1988. PMID: 3367308

5

Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.

Asthana S, Greig NH, Holloway HW, Raffaele KC, Berardi A, Schapiro MB, Rapoport SI, Soncrant TT. Asthana S, et al. Among authors: greig nh. Clin Pharmacol Ther. 1996 Sep;60(3):276-82. doi: 10.1016/S0009-9236(96)90054-5. Clin Pharmacol Ther. 1996. PMID: 8841150 Clinical Trial.

6

Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.

Yu QS, Pei XF, Holloway HW, Greig NH, Brossi A. Yu QS, et al. Among authors: greig nh. J Med Chem. 1997 Aug 29;40(18):2895-901. doi: 10.1021/jm970210v. J Med Chem. 1997. PMID: 9288171

7

The effects of GLP-1 on insulin release in young and old rats in the fasting state and during an intravenous glucose tolerance test.

De Ore K, Greig NH, Holloway HW, Wang Y, Perfetti R, Egan JM. De Ore K, et al. Among authors: greig nh. J Gerontol A Biol Sci Med Sci. 1997 Sep;52(5):B245-9. doi: 10.1093/gerona/52a.5.b245. J Gerontol A Biol Sci Med Sci. 1997. PMID: 9310073

8

Phenserine, a novel acetylcholinesterase inhibitor, attenuates impaired learning of rats in a 14-unit T-maze induced by blockade of the N-methyl-D-aspartate receptor.

Patel N, Spangler EL, Greig NH, Yu QS, Ingram DK, Meyer RC. Patel N, et al. Among authors: greig nh. Neuroreport. 1998 Jan 5;9(1):171-6. doi: 10.1097/00001756-199801050-00035. Neuroreport. 1998. PMID: 9592071

9

Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.

Yu Q, Greig NH, Holloway HW, Brossi A. Yu Q, et al. Among authors: greig nh. J Med Chem. 1998 Jun 18;41(13):2371-9. doi: 10.1021/jm9800494. J Med Chem. 1998. PMID: 9632370

10

Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.

al-Jafari AA, Kamal MA, Greig NH, Alhomida AS, Perry ER. al-Jafari AA, et al. Among authors: greig nh. Biochem Biophys Res Commun. 1998 Jul 9;248(1):180-5. doi: 10.1006/bbrc.1998.8931. Biochem Biophys Res Commun. 1998. PMID: 9675107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters